Vitamin D
DrugFat-soluble vitamin D injection contain of 300,000 IU vitamin D that given via intramuscular injection
Other names: Cholecalciferol
NCT Number: NCT03248544
Vitamin D supplementation not only has beneficial effects on morbidity and mortality in critically ill patients but it may also lead to alleviate of seizure, brain edema, infection, pain and some other perioperative complications, possibly in part through an attenuation of the immune response.In this trial patients with brain tumor under craniotomy will receive a single high dose vitamin D compared to control group.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
A randomized, double blind, controlled trial will be conducted in neurosurgery ward, operating room (OR) and intensive care unit (ICU) in Tehran, Iran. After a full review of the inclusion and exclusion criteria and explanation of the risks and benefits of the study, written consent form will be completed. The participants are 60 eligible hospitalized patients that diagnosed with brain tumor and need to craniotomy, aged ≥ 18 years. Intervention patients will be received an intramuscular (IM) single dose of vitamin D (300000 IU). Patients will be evaluated for occurrence of perioperative complications and clinical outcomes immediately after surgery until 1 month later and 1 and 6 months mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fat-soluble vitamin D injection contain of 300,000 IU vitamin D that given via intramuscular injection
Other names: Cholecalciferol
No intervention
Time frame: Postoperative day 5
25(OH) will be measured after surgery
Time frame: During surgery, recovery and hospitalization (5 days post op)
Complications in operating room, recovery room, ICU and neurosurgery ward
Time frame: 30 days after surgery
Complications after hospital discharge
Time frame: 30 days
Length of stay in ICU is measured
Time frame: 30 days
Length of stay in hospital is measured
Time frame: 30 days
Mortality during hospitalization or 1 month after surgery
Time frame: 6 months
Mortality during 6 months after surgery
Shahid Beheshti University
Other
Effect of Single High Dose Vitamin D3 on Peri-operative and Post-operative Complications and Clinical Outcomes in Patients Under Craniotomy for Brain Tumor Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716579
Brain Diseases, Brain Neoplasms
Ljubljana, Slovenia
View Trial DetailsNCT05776602
Brain Diseases, Brain Neoplasms
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT07238322
Brain Diseases, Brain Neoplasms
San Francisco, California, United States
View Trial DetailsNCT07499141
Astrocytoma, Brain Diseases
Alessandria, Italy
View Trial Details